20 years of experience as a senior business leader, most recently as CEO of European-focused specialty pharmaceutical company Merus Labs. Previously served as CEO of Teva Canada and Taro Canada.
20 years of experience in international pharmaceuticals, previously CFO of three publicly held Canadian companies - most recently as CFO of Merus Labs
15 years of experience in finance and operations. Prior to founding Canna Farms, was Managing Director of Amberwood Homes.
25 years of experience in the pharmaceutical industry in western and eastern Europe, including executive positions at Sanofi and Wyeth.
45 years of engineering, design, construction, project management experience. Commissioned multiple industrial food grade facilities.
20 years of experience in the premium segment of the highly regulated brewing industry including the President and co-founder of Muskoka Brewery.
20 years of experience in sales and marketing in the beverage and alcohol industry, including roles at Diageo and Cowbell Brewing Co.
20 years of legal experience starting at Stikeman Elliott specializing in corporate litigation.
Board of Directors
Paul Lucas, Chairman
Former CEO of Glaxo Canada with significant board experience in for-profit & non-profit sectors.
Barry Fishman, Chief Executive Officer
Established CEO, including European-focused specialty pharmaceutical company Merus Labs and previously at Teva Canada and Taro Canada.
Co-founder of Canna Farms, a seasoned entrepreneur with broad cannabis cultivation and operational experience.
Corporate finance and M&A Advisor with experience ranging from startups to Canada’s largest public companies.
Member of Parliament, Municipal Counsellor and successful entrepreneur.
The only way we can provide our customers and patients with best-in-class offerings is with the support of some of the world’s best scientific advisors. Introducing some of the foremost experts in cannabis research and plant science.
Raphael Mechoulam, PhD
The world-renowned cannabis scientist that discovered tetrahydrocannabinol (THC) and cannabidiol (CBD).
Mike Dixon, PhD
Leading globally recognized plant scientist and University of Guelph professor specializing in controlled environment cultivation systems.
Richa Love, MD
Industry leader in research and clinical application of cannabinoid-based therapies and formulations for specific medical conditions.